(HealthDay)—AstraZeneca is the latest drug company to release details about human tests of its COVID-19 vaccine in response to public demand for such information. Americans have increasing doubts ...

AstraZeneca PLC (LSE:AZN, NYSE:AZN), the FTSE 100 drugmaker, has had a decent third quarter, with the patent cliff on its ...

(Reuters) - AstraZeneca topped analysts' estimates for quarterly profit and reiterated its targets for the year on Wednesday, as the British drugmaker benefited from higher demand for some of its ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker. Traders cited a report from the ...

(Reuters) - British drugmaker AstraZeneca forecast revenue growth for this year of around 10% on Friday, as it factored in a hit from the coronavirus outbreak in China and fell short of analysts' ...

Investors and analysts said AstraZeneca - the UK's biggest drugmaker - had little need for a transformative acquisition despite potential cost benefits AstraZeneca investors punished the ...